Literature DB >> 29558217

Combination Chlorambucil/Firocoxib or Chlorambucil/Prednisolone Treatment for Inflammatory Colorectal Polyps in Miniature Dachshunds.

Akira Murakami1, Ayami Shibahashi1, Ryota Iwasaki1, Mifumi Kawabe1, Mami Murakami1, Hiroki Sakai1, Takashi Mori1.   

Abstract

Inflammatory colorectal polyps (ICRP), which are more commonly recognized in miniature dachshunds, are thought to represent an immune-mediated disease. This retrospective case series describes six miniature dachshunds with refractory ICRP, who were treated with chlorambucil (CLB) combined with firocoxib or prednisolone. Improvement in clinical manifestations was seen in five of the six dogs by the end of the study period; four were treated with CLB/firocoxib and one with CLB/prednisolone. One dog had nonregenerative anemia after 23 mo of treatment with CLB, but whether there was a causative relationship was unclear. No severe adverse events were observed during treatment in the remaining five dogs. CLB in combination with firocoxib or prednisolone appears to be an effective alternative treatment for ICRP in dogs. Further studies are needed to confirm the effectiveness and long-term complications of CLB treatment for ICRP in dogs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29558217     DOI: 10.5326/JAAHA-MS-6663

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  2 in total

1.  Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines.

Authors:  Edina Karai; Kornélia Szebényi; Tímea Windt; Sára Fehér; Eszter Szendi; Valéria Dékay; Péter Vajdovich; Gergely Szakács; András Füredi
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

2.  Comparison of the efficacy of cyclosporine and leflunomide in treating inflammatory colorectal polyps in miniature dachshunds.

Authors:  Akiyoshi Tani; Taisuke Seno; Nozomu Yokoyama; Taisuke Nakagawa; Hirotaka Tomiyasu; Yuko Goto-Koshino; Hajime Tsujimoto; Koichi Ohno
Journal:  J Vet Med Sci       Date:  2020-02-14       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.